📋 Chinook Therapeutics, Inc. (KDNY) - Clinical Trial Update
Filing Date: 2022-05-20
Accepted: 2022-05-20 16:11:07
Event Type: Clinical Trial Update
Event Details:
Chinook Therapeutics Inc (KDNY) Announces Clinical Trial Update
Chinook Therapeutics Inc (KDNY) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: reductions, observed
Diseases/Conditions: kidney diseases
Clinical Stage: phase 1, Phase 1
Collaboration: ERA
expected in the second half of 2022
targeting Hit 1 in the multi-hit pathogenesis of IgAN. • BION-1301
📋 Chinook Therapeutics, Inc. (KDNY) - Clinical Trial Update
Filing Date: 2022-05-20
Accepted: 2022-05-20 16:11:07
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: